These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Changes in fluorosis clinical manifestations under treatment and during post-contact period]. Odinokaia VA Med Tr Prom Ekol; 2007; (3):27-31. PubMed ID: 17494308 [TBL] [Abstract][Full Text] [Related]
6. [Report of a case of so-called "neighborhood fluorosis"]. Schmidt CW; Franke J Z Gesamte Hyg; 1976 Aug; 22(8):611-5. PubMed ID: 969756 [No Abstract] [Full Text] [Related]
8. [Professional lesions of the bones caused by the action of fluorides (the so-called massive fluorosis of bones)]. GRINBERG AV Vestn Rentgenol Radiol; 1955; (6):58-64. PubMed ID: 13312192 [No Abstract] [Full Text] [Related]
9. [The management of vomiting and nausea with zofran during the chemotherapy of malignant tumors]. Seliuzhitskiĭ IV; Eliseev SN; Ivanov AI Voen Med Zh; 1994 Oct; (10):34-6. PubMed ID: 7831851 [No Abstract] [Full Text] [Related]
10. [Clinical and x-ray diagnosis and diagnosis and classification of occupational fluorosis]. Zhovtiak EP; Semennikova TK; Iarina AL; Shirokov VA; Likhacheva EI; Kuznetsova EP Med Tr Prom Ekol; 2000; (3):17-20. PubMed ID: 10826367 [TBL] [Abstract][Full Text] [Related]
11. [Possibilities of roentgenodensitometry in the diagnosis of fluorosis]. Fesenko NP Vrach Delo; 1973 Aug; 8():133-7. PubMed ID: 4771671 [No Abstract] [Full Text] [Related]
12. [Hemostasis disorders in patients with occupational fluorosis are risk factors for IHD]. Filimonov SN; Luk'ianova MV; Razumov VV; Koriakin AM; Gorbatovskiĭ IaA; Epifantseva NN; Danilov IP Med Tr Prom Ekol; 2005; (4):35-9. PubMed ID: 15921192 [TBL] [Abstract][Full Text] [Related]
13. A quanttative microscopic study of bone-remodeling and balance in a human with skeletal fluorosis. Epker BN Clin Orthop Relat Res; 1967; 55():87-93. PubMed ID: 6079754 [No Abstract] [Full Text] [Related]
14. [Genetic markers of occupational susceptibility to fluorosis]. Danilov IP; Protasov VV; Lotosh EA; Luzina FA Med Tr Prom Ekol; 2001; (7):30-3. PubMed ID: 11530516 [TBL] [Abstract][Full Text] [Related]
15. [Nifurantin side effects in a kidney dispensary]. Rüdiger R Z Gesamte Inn Med; 1967 Aug; 22(15):461-3. PubMed ID: 5242972 [No Abstract] [Full Text] [Related]
16. [Immunosuppressive therapy of rheumatoid arthritis (progressive chronic polyarthritis) with azathioprine]. Klein G; Kalb R Z Rheumaforsch; 1969; 28(1):1-5. PubMed ID: 5258201 [No Abstract] [Full Text] [Related]
17. [Apropos of fluoric osteopetrosis]. Herbert JJ; Viard JL Rhumatologie; 1966; 18(6):225-9. PubMed ID: 5925945 [No Abstract] [Full Text] [Related]
19. [Analysis of probability of development of chronic occupational poisoning (based on the example of fluorosis)]. Shcherbakov SV; Farberov DS Gig Tr Prof Zabol; 1978 Feb; (2):18-21. PubMed ID: 640467 [No Abstract] [Full Text] [Related]
20. A case of endemic fluorosis of bone in the Cape Province. WERBELOFF L; SENDER B S Afr Med J; 1958 Jul; 32(29):720-3. PubMed ID: 13580465 [No Abstract] [Full Text] [Related] [Next] [New Search]